Ethinyl Estradiol/Norgestimate

炔雌醇/诺孕酯

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEthinyl Estradiol/Norgestimate
Drug Alias Name炔雌醇+诺孕酯Norgestimate+EthinylestradiolNorgestimate/EthinylestradiolOrtho Tri-CyclenOrtho-Cyclen +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors agonists
TargetsEstrogen receptors
Therapy Area/IndicationsVasomotor symptomVulvar and vaginal atrophyContraception +[7] 
Global Approved IndicationsContraceptionAcne Vulgaris
Approved Indications in ChinaN/A
Original Approved Country/TerritoryBelgium
Original Approved Date1988/03/01
Country/TerritoryBelgiumUnited StatesNetherlands +[4] 
CombinationsYes Ethinyl Estradiol
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesMcneil Consumer & Specialty Pharmaceuticals, A Division Of Mcneil-Ppc IncJanssen Pharmaceuticals IncBenha University +[5] 
Active IndicationsContraception
Inactive IndicationsVasomotor symptomVulvar and vaginal atrophyAcne Vulgaris +[6] 

Other Information

ATC CodeG03AA11G03AB09
Related LinksN/A